Brief: PharmaSGP FY 2021 Revenues At Around EUR 65 Mln
Feb 17 (Reuters) - PHARMASGP HOLDING SE PSGG.DE :
* ACHIEVES RECORD REVENUES IN 2021 AND EXCEEDS ANALYSTS'
EXPECTATIONS
* STILL EXPECTS AN ADJUSTED EBITDA MARGIN OF BETWEEN 27% AND
31%
FOR 2021
* ACHIEVED REVENUES OF AROUND EUR 65 MILLION IN FINANCIAL
YEAR
2021, REACHING UPPER END OF PUBLISHED GUIDANCE (EUR 60 MILLION
TO EUR 65 MILLION)
Source text for Eikon: ID:nEQ16R4Qka
Further company coverage: PSGG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on PharmaSGP Holding SE
See all newsBrief: PharmaSGP Holding Outlook FY Revenue EUR 132-138 Million
Brief: PharmaSGP Holding Outlook FY Adjusted EBITDA EUR 37-39 Million
Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 9.2 Million
Brief: PharmaSGP Holding Outlook FY Revenue EUR 122-128 Million
Brief: PharmaSGP Holding 9M Adjusted EBITDA EUR 27 Million